Eli Lilly loses appeal of $183.7 million Medicaid fraud award
By Jonathan Stempel (Reuters) -A federal appeals court on Thursday rejected Eli Lilly’s appeal of...
By Jonathan Stempel (Reuters) -A federal appeals court on Thursday rejected Eli Lilly’s appeal of...
(Reuters) -Delta Air Lines on Thursday reaffirmed its full-year and current-quarter earnings forecasts, betting on...
(Reuters) -Nvidia said on Tuesday it would launch a new artificial intelligence chip by the...
(Clarifies timing of Goldman Sachs note which went to clients on September 2, not this...
By Jeff Mason and Steve Holland WASHINGTON (Reuters) – U.S. President Donald Trump feels “very...
By Tatiana Bautzer NEW YORK (Reuters) – Citigroup Chief Financial Officer Mark Mason said at...
By Milana Vinn and Max A. Cherney NEW YORK -ASML, a crucial supplier of advanced...
By Dietrich Knauth and Daniel Wiessner (Reuters) -A U.S. appeals court on Friday declined to...
By Olesya Astakhova, Dmitry Zhdannikov and Ahmed Rasheed LONDON/MOSCOW/BAGHDAD (Reuters) -OPEC+ is set to agree...
By Amy Tennery, Maria Tsvetkova and Jeff Mason NEW YORK (Reuters) – The U.S. Open...